AlphaStocks
4.5
Weak

Concentra Group Holdings Parent, Inc. (CON)

Health Care / Health Care Services

S&P SmallCap 600

$21.23

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#722out of 1127 in Health Care

Is Concentra Group Holdings Parent, Inc. a Good Investment in 2026?

Concentra Group Holdings Parent, Inc. (CON) scores 4.5 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Concentra Group Holdings Parent, Inc. as Attractive (Top half (rank 33%)). However, the Graham model rates it Caution — Significantly above fair value. Concentra Group Holdings Parent, Inc. currently trades below its estimated fair value of $32, suggesting potential upside. Concentra Group Holdings Parent, Inc. ranks #722 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E16.4ROE42.7Market Cap3BDiv Yield1.2

Estimated Fair Value

$32.2034% below

Fair value above market price. ROE of 43% signals strong profitability. P/E of 16x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Attractive

Top half (rank 33%)

Frequently Asked Questions

Is Concentra Group Holdings Parent, Inc. (CON) a good investment?
Based on AlphaStocks' composite analysis, Concentra Group Holdings Parent, Inc. (CON) scores 4.5 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. ROE of 43% signals strong profitability. P/E of 16x is moderate for this quality level.
What is Concentra Group Holdings Parent, Inc.'s Piotroski F-Score?
Concentra Group Holdings Parent, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CON overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $32, CON appears undervalued. The stock currently trades 34% below its estimated fair value. Fair value above market price. ROE of 43% signals strong profitability. P/E of 16x is moderate for this quality level.
How does CON compare to other Health Care stocks?
Concentra Group Holdings Parent, Inc. ranks #722 out of 1127 stocks in the Health Care sector, placing it in the top 64% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CON?
AlphaStocks evaluates CON using five proven investment models. Piotroski: Neutral; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.5/10.

Similar Stocks

PARRFTIAZN

Compare CON with

CON vs PARRCON vs FTICON vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer